Blueprint Medicines Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
77.53
|
|
Average Rating
|
3.95
|
|
# Strong Buys
|
8
|
|
# Buys
|
4
|
|
# Holds
|
6
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.49
|
-2.23
|
0.26
|
10.44%
|
|
2022-06-30
|
-2.23
|
-2.68
|
-0.45
|
-20.18%
|
|
2022-03-31
|
-1.86
|
-1.79
|
0.07
|
3.76%
|
|
2021-12-31
|
-1.65
|
-5.40
|
-3.75
|
-227.27%
|
|
2021-09-30
|
-1.63
|
-2.00
|
-0.37
|
-22.70%
|
|
2021-06-30
|
-1.86
|
-1.86
|
0.00
|
0.00%
|
|
2021-03-31
|
-1.87
|
-1.72
|
0.15
|
8.02%
|
|
2020-12-31
|
-1.62
|
-1.53
|
0.09
|
5.56%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.70
|
|
2021-12-31
|
-10.98
|
|
2020-12-31
|
5.24
|
|
2019-12-31
|
-7.30
|
|
2018-12-31
|
-5.40
|
|
2017-12-31
|
-3.89
|
|
2016-12-31
|
-2.64
|
|
2015-12-31
|
-10.09
|